Science Explorer Interactive view Map
Company · South San Francisco · United States

Exelixis (United States)

In research, Exelixis (United States) stands highest in Life Sciences (#5,855 of 14,347 worldwide), over all time.

exelixis.comROR OpenAlex
World rank, all time
#13,335
of 42,892
Rank in United States
#2,928
of 8,685
Research works
291
▲ 9% vs 2013–17
Citations
16k
56.3 per fractional work
Top-10% rate
21.8%
record average 16.5%
Open access
50%
world 28%

What is Exelixis (United States) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Life SciencesDomain #5,855 of 14,347 31.0%125

Each strip is that field’s whole ranked pool, with the notch where Exelixis (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.17× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.87× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 7.37× its world share, 3 worksImmunology and Micro…Neuroscience: 0.35× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.85× its world share, 1 worksPharmacology, Toxico…Chemistry: 1.42× its world share, 1 worksChemistryComputer Science: 0.43× its world share, 1 worksComputer ScienceEarth and Planetary Sciences: 0.42× its world share, 0 worksEarth and Planetary …Engineering: 0.37× its world share, 2 worksEngineeringEnvironmental Science: 0.20× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.07× its world share, 0 worksMaterials ScienceMathematics: 1.36× its world share, 1 worksMathematicsPhysics and Astronomy: 0.10× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.02× its world share, 0 worksHealth ProfessionsMedicine: 2.60× its world share, 21 worksMedicineArts and Humanities: 0.09× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.08× its world share, 0 worksBusiness, Management…Decision Sciences: 0.78× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.54× its world share, 1 worksEconomics, Econometr…Social Sciences: 0.41× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.4×. Every wedge is a field page.

Who are the top researchers at Exelixis (United States)?

Ranked on the composite score, Nara Shiru lead among researchers whose main affiliation is Exelixis (United States).

  1. 1 Nara Shiru United States · #1,633,865 worldwide 0 citations · 15 works
All ranked researchers at Exelixis (United States)

Which keywords describe research at Exelixis (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Chemotherapy, Tumor Microenvironment, Metastatic, Molecular Characterization, Genetic Mutations, Prognostic Factors and Therapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Immunotherapy5▲ 18×9 topics
  2. Chemotherapy4▲ 15×11 topics
  3. Tumor Microenvironment4▲ 20×5 topics
  4. Metastatic4▲ 138×2 topics
  5. Molecular Characterization3▲ 41×4 topics
  6. Genetic Mutations3▲ 16×3 topics
  7. Treatment3▲ 5.5×2 topics
  8. Prognostic Factors3▲ 14×5 topics
  9. Clinical Guidelines2▲ 20×3 topics
  10. Machine Learning2▲ 1.77×14 topics
  11. Therapy2▲ 30×2 topics
  12. Cancer2▲ 3.8×11 topics
  13. Nephron-Sparing Surgery2▲ 154×1 topic
  14. Renal Cell Carcinoma2▲ 154×1 topic
  15. Cancer Therapy2▲ 8.7×7 topics
  16. Glycosylation2▲ 43×3 topics
  17. Inflammation2▲ 2.1×13 topics
  18. Monoclonal Antibodies2▲ 49×3 topics
  19. Angiogenesis2▲ 13×6 topics
  20. Therapeutic Antibodies2▲ 61×2 topics
  21. Breast Cancer2▲ 17×3 topics
  22. Targeted Therapy2▲ 18×4 topics
  23. Antibody Engineering2▲ 70×1 topic
  24. Fc Receptors2▲ 70×1 topic
  25. Monoclonal Antibody2▲ 73×2 topics
  26. HER22▲ 120×1 topic
  27. Immune Checkpoint Blockade2▲ 32×1 topic
  28. Neoadjuvant Therapy2▲ 15×4 topics
  29. PD-1 and PD-L12▲ 32×1 topic
  30. Trastuzumab2▲ 75×1 topic
  31. BRAF Mutation1▲ 42×2 topics
  32. Cancer Immunotherapy1▲ 20×2 topics
  33. PET Imaging1▲ 18×3 topics
  34. Clinical Practice Guidelines1▲ 5.3×5 topics
  35. Immune Regulation1▲ 23×2 topics
  36. Immunity1▲ 6.3×4 topics
  37. Pancreatic Cancer1▲ 24×1 topic
  38. Surgical Complications1▲ 32×1 topic
  39. Cost of Care1▲ 79×1 topic
  40. Financial Toxicity1▲ 79×1 topic

Which research topics does Exelixis (United States) publish most on?

By volume in 2022–2025: Renal cell carcinoma treatment, Monoclonal and Polyclonal Antibodies Research, Cancer Immunotherapy and Biomarkers and HER2/EGFR in Cancer Research.

Renal cell carcinoma treatment: 2 fractional worksMonoclonal and Polyclonal Antibodies Research: 2 fractional worksCancer Immunotherapy and…2Cancer Immunotherapy and Biomarkers: 2 fractional worksHER2/EGFR in Cancer Rese…2HER2/EGFR in Cancer Research: 2 fractional worksPancreatic and Hepatic Oncology Research: 1 fractional worksEconomic and Financial Impacts of Cancer: 1 fractional worksPeptidase Inhibition and…1Peptidase Inhibition and Analysis: 1 fractional worksColorectal Cancer Treatments and Studies: 1 fractional worksPhagocytosis and Immune Regulation: 1 fractional worksCancer Genomics and Diagnostics: 1 fractional works
Pulmonary and Respiratory MedicineRadiology, Nuclear Medicine and ImagingOncologyEconomics and Econometrics2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Renal cell carcinoma treatment Pulmonary and Respiratory Medicine 2 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 2 works
  4. 4 HER2/EGFR in Cancer Research Oncology 2 works
  5. 5 Pancreatic and Hepatic Oncology Research Oncology 1 works
  6. 6 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
  7. 7 Peptidase Inhibition and Analysis Oncology 1 works
  8. 8 Colorectal Cancer Treatments and Studies Oncology 1 works
  9. 9 Phagocytosis and Immune Regulation Immunology 1 works
  10. 10 Cancer Genomics and Diagnostics Cancer Research 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available49.6%not open50.4%

World: 28% of research is openly available.

with international co-authors26.9%domestic only73.1%

World: 19% is written across borders.

How has Exelixis (United States)'s research output changed?

Output in 2018–2022 was 9% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in South San Francisco

All research institutions in South San Francisco

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.